Bonnie Ky, MD, MSCE, FACC, Ronald M. Witteles, MD, Marielle Scherrer-Crosbie, MD, PhD, and W. Greg Hundley, MD discuss the topic of statin cardioprotection, the STOP-CA trial presented at ACC.23, the PREVENT study published in NEJM Evidence, and the key takeaways of these two studies. Future directions and goals for the field are also discussed.
Ronald M. Witteles, MD and Sharmila Dorbala, MD, MPH discuss key takeaways from the ACC.23 session on Cardiac Amyloidosis in Real-World Clinical Practice
Commentary by Dr. Julia Grapsa
Commentary by Dr. Sean Pinney
Commentary by Dr. Paul Heidenreich
Commentary by Dr. Julia Grapsa
Commentary by Dr. Julia Grapsa and Dr. Alejandro Jimenez
Commentary by Drs. Julia Grapsa, Alexandra Nicholas, Malamo Countouris, and Edoardo Zancanaro
Commentary by Dr. Emile Daoud
Commentary by Dr. Emile Daoud
Commentary by Dr. Emile Daoud
Commentary by Dr. Emile Daoud
Commentary by Dr. Eric Bates and Dr. Brendan Caprio
Commentary by Dr Eue-Keun Choi
Audio Summary of the February Issue with Introduction by Dr. Bonnie Ky
Commentary by Dr. Olatokunbo Osibogun
Commentary by Dr. Otis Brawley and Dr. Michael LeCompte
Commentary by Dr. Shalini Moningi
Commentary by Dr. Ilana Schlam
Commentary by Dr. Lavanya Kondapalli
Commentary by Dr. Ronald Krone
Commentary by Dr Davide Capodanno
Commentary by Dr Carl J. Lavie
Commentary by Dr William F. Fearon
Commentary by Dr Raul Santos